Major gaps in hepatitis C care identified as new drugs, screening efforts emerge

Significant gaps in hepatitis C care identified in a new meta-analysis will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs. In the largest study of its kind, the team examined data culled from 10 studies between 2003 and 2013 and found that less than 10 percent of people infected with hepatitis C in the United States -- 330,000 of nearly 3.5 million people -- were cured (achieved v...